Increased Aβ levels as observed in AD lead to peroxisomal dysfunction and reduced AGPS protein stability, resulting in reduced AGPS protein level and reduced plasmalogen de novo synthesis [39]. The gene discussed is AGPS; the disease is Alzheimer disease.